Estimated Infection and Vaccine Induced SARS-CoV-2 Seroprevalence in Israel among Adults, January 2020–July 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in Israel in February 2020 and spread from then. In December 2020, the FDA approved an emergency use authorization of the Pfizer-BioNTech vaccine, and on 20 December, an immunization campaign began among adults in Israel. We charac...
Main Authors: | Ravit Bassal, Lital Keinan-Boker, Dani Cohen, Ella Mendelson, Yaniv Lustig, Victoria Indenbaum |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/10/1663 |
Similar Items
-
IgG Serum Antibodies to <i>Shigella sonnei</i> Lipopolysaccharide Are Inversely Associated with the Incidence of Culture-Proven <i>S. sonnei</i> Shigellosis in Israeli Children and Adolescents
by: Valeria Asato, et al.
Published: (2024-02-01) -
Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 – 2019 outbreak
by: Ravit Bassal, et al.
Published: (2021-05-01) -
Israel since 1980 /
by: Porat, Guy Ben
Published: (2008) -
Public Housing in Israel: From Welfare State to Neoliberalism
by: Ravit Hananel -
Non-Dairy Animal Protein Consumption Is Positively Associated with Overweight and Obesity in Israeli Adolescents
by: Chen Dor, et al.
Published: (2022-07-01)